A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Clinical trial NCT01318434 · COMPLETED
Trial details
- NCT number
- NCT01318434
- Sponsor
- Euthymics BioScience, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-02-01
- Enrollment
- 342
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.